Today, on the 22nd of February, we take a moment to celebrate the advancements in Far-UVC technology at 222 nm. Over the past year, we have witnessed remarkable progress in research and real-world applications that are shaping the future of infection prevention. As we reflect on these developments, it is evident that Far-UVC is not just a theoretical innovation but a tangible solution to some of the most pressing health challenges we face today.
A Game-Changer in Combating Antibiotic-Resistant Bacteria
The rise of antibiotic-resistant bacteria has become one of the most critical threats to modern medicine. Traditional decontamination methods are struggling to keep up, and new strategies are needed to combat these resilient pathogens and emerging threats. Far-UVC light has emerged as a highly effective solution, capable of inactivating antibiotic-resistant bacteria without harming human skin or eyes. Over the past year, studies have reinforced the potential of 222 nm light in reducing the spread of these dangerous bacteria in healthcare and pharmaceutical environments. *
Taking on Candida Auris
Another rising challenge is Candida auris, a multidrug-resistant fungal pathogen that has been spreading globally. Its persistence on surfaces and in healthcare settings makes it extremely difficult to control. However, recent studies have demonstrated that Far-UVC is capable of effectively reducing Candida auris contamination, providing a new layer of protection in hospitals, laboratories, and cleanrooms. **
Far-UVC Preventing Mold Growth Even with Low Doses
Mold contamination in controlled environments, such as hospitals and pharmaceutical facilities, presents significant challenges to maintaining product safety and regulatory compliance. Emerging research has shown that even low doses of Far-UVC can effectively mitigate mold growth without the need for aggressive chemical treatments. This finding is particularly valuable for industries that require stringent microbial control while minimizing chemical exposure. ***
Moving from the Laboratory to the Real World
One of the most exciting developments in the past year is the transition of Far-UVC research from controlled laboratory settings to real-world environments. A landmark study demonstrated a 99% reduction of airborne viruses in an occupied space using Far-UVC light****. Far-UVC holds the potential of reducing the spread of airborne pathogens in public spaces, including hospitals, airports and workplaces. The implications for global health and infection prevention are profound.
A significant example of this shift is an ongoing controlled phase II trial in Denmark, evaluating the clinical impact of Far-UVC in long-term care (LTC) facilities. The study, conducted in 12 public LTC facilities in Vejle with 542 residents, aims to determine whether Far-UVC can effectively reduce hospitalizations due to viral and bacterial infections. With one facility placing Far-UVC lamps in common areas and another extending coverage to residents’ apartments, this study will provide valuable insights into the real-world application of Far-UVC for infection control. This could pave the way for a large-scale phase III trial, further solidifying Far-UVC as a crucial tool in protecting vulnerable populations. *****
At UV Medico, we remain committed to advancing Far-UVC technology and its implementation in real-world applications. As research continues to confirm its effectiveness, we are excited to see how this innovation will continue to transform public health and safety.
Happy 222 Day – and here’s to a future where the air we breathe is safer for everyone!
UV222™
UV222 Linear
UV222 Downlight
Vertex 222.png)
UV222 Pendant.png)
UV222 Booth.png)
UV222 Step-On.png)
UV222 Cleanroom Downlight.png)
UV222 Material Airlock
UV222 Ambulance
UV222 Industrial
Insights
Science
Compliance
Sign up to our newsletter
Christian K. Holm
Mads Emil Bandholm : 05 Jun, 2024
